Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
0.00%
)
US TECH 100
24,066.80
(
0.21%
)
Dow Jones
46,946.41
(
0.00%
)
Brent Oil
100.08
(
1.81%
)
Bitcoin
73,785.42
(
-1.41%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 66761

Monday, 05/02/2011 2:01:24 AM

Monday, May 02, 2011 2:01:24 AM

Post# of 257251
PFE has apparently reversed itself and now considers cardiovascular medicine a core area of expertise. From Monday’s WSJ interview with CEO, Ian Read:

http://online.wsj.com/article/SB20001424052748704473104576293083128749142.html

“We've declared a core, which is neuroscience, cardiovascular medicine, oncology, inflammation, immunology and vaccines. We have these three specialized units for pain, sensory disorders and biosimilars.”

About 2.5 years ago, PFE said it was withdrawing from R&D in the CV arena: #msg-32523077.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now